Pharmanutra SpA
MIL:PHN
Cash Flow Statement
Cash Flow Statement
Pharmanutra SpA
Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||
Net Income |
9
|
9
|
8
|
14
|
14
|
17
|
11
|
15
|
14
|
15
|
15
|
16
|
15
|
17
|
14
|
12
|
13
|
10
|
|
Depreciation & Amortization |
1
|
1
|
1
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
|
Other Non-Cash Items |
1
|
1
|
1
|
(1)
|
(1)
|
(1)
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
(3)
|
(2)
|
|
Change in Working Capital |
(3)
|
(2)
|
2
|
(4)
|
(4)
|
(4)
|
1
|
(1)
|
4
|
2
|
1
|
(2)
|
(4)
|
(10)
|
(9)
|
(3)
|
(1)
|
1
|
|
Cash from Operating Activities |
6
N/A
|
9
+35%
|
12
+38%
|
11
-10%
|
12
+9%
|
14
+23%
|
15
+2%
|
17
+15%
|
20
+20%
|
20
-4%
|
19
-5%
|
16
-13%
|
14
-10%
|
11
-27%
|
9
-16%
|
12
+36%
|
12
-1%
|
12
-1%
|
|
Investing Cash Flow | |||||||||||||||||||
Capital Expenditures |
(1)
|
(2)
|
(5)
|
(4)
|
(2)
|
(2)
|
(2)
|
(3)
|
(5)
|
(6)
|
(9)
|
(10)
|
(23)
|
(26)
|
(27)
|
(28)
|
(13)
|
(10)
|
|
Other Items |
(0)
|
(0)
|
(0)
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(11)
|
(1)
|
(1)
|
(1)
|
9
|
(1)
|
(0)
|
|
Cash from Investing Activities |
(1)
N/A
|
(2)
-84%
|
(5)
-126%
|
(3)
+43%
|
(1)
+80%
|
(1)
-92%
|
(2)
-116%
|
(3)
-27%
|
(6)
-76%
|
(6)
-15%
|
(10)
-54%
|
(21)
-111%
|
(24)
-14%
|
(26)
-11%
|
(28)
-7%
|
(20)
+31%
|
(15)
+25%
|
(11)
+28%
|
|
Financing Cash Flow | |||||||||||||||||||
Net Issuance of Common Stock |
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
|
Net Issuance of Debt |
(1)
|
0
|
(0)
|
0
|
(5)
|
(5)
|
(5)
|
0
|
5
|
4
|
11
|
11
|
11
|
12
|
14
|
8
|
10
|
9
|
|
Cash Paid for Dividends |
(3)
|
(5)
|
(5)
|
(4)
|
(4)
|
0
|
(6)
|
(6)
|
(6)
|
0
|
(7)
|
(7)
|
(7)
|
0
|
(8)
|
(8)
|
(8)
|
0
|
|
Other |
(1)
|
(5)
|
(4)
|
(4)
|
1
|
1
|
3
|
3
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
Cash from Financing Activities |
(5)
N/A
|
(10)
-85%
|
(9)
+3%
|
(8)
+13%
|
(8)
-6%
|
(8)
+2%
|
(8)
+4%
|
(3)
+61%
|
(2)
+39%
|
(4)
-130%
|
1
N/A
|
2
+179%
|
2
+4%
|
3
+35%
|
4
+54%
|
(3)
N/A
|
(1)
+82%
|
(0)
+63%
|
|
Change in Cash | |||||||||||||||||||
Net Change in Cash |
0
N/A
|
(3)
N/A
|
(3)
+20%
|
(0)
+93%
|
3
N/A
|
5
+85%
|
4
-14%
|
11
+148%
|
13
+21%
|
9
-33%
|
9
+8%
|
(3)
N/A
|
(7)
-167%
|
(13)
-80%
|
(15)
-16%
|
(10)
+33%
|
(3)
+70%
|
1
N/A
|
|
Free Cash Flow | |||||||||||||||||||
Free Cash Flow |
6
N/A
|
7
+19%
|
7
+6%
|
7
-3%
|
10
+46%
|
13
+27%
|
13
-2%
|
14
+13%
|
15
+8%
|
14
-11%
|
10
-30%
|
6
-36%
|
(9)
N/A
|
(15)
-75%
|
(19)
-21%
|
(16)
+13%
|
(1)
+93%
|
2
N/A
|